© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Search results for

Tip: Use operators exact match "", AND, OR to customise your search. You can use them separately or you can combine them to find specific content.
There are 369,438 results that match your search.369,438 results
  • Swiss pharmaceutical group Roche has announced its intention to issue a combination of stock and exchangeable bonds. Some $1bn in new capital will raised through the sale of straight stock in Genentech, the US bio-tech group using human genetic information to discover, develop, manufacture and market human pharmaceuticals. The divestment will take the form of two tranches - a the sale of common shares and the offer of LYONs convertible into Genentech shares.
  • Swiss pharmaceutical group Roche has announced its intention to issue a combination of stock and exchangeable bonds. Some $1bn in new capital will raised through the sale of straight stock in Genentech, the US bio-tech group using human genetic information to discover, develop, manufacture and market human pharmaceuticals. The divestment will take the form of two tranches - a the sale of common shares and the offer of LYONs convertible into Genentech shares.
  • Rating: AAA Amount: Eu500m Öffentlicher Pfandbrief series k522
  • The Finnish government's divestment of Sonera has been an outstanding success, with global co-ordinators Goldman Sachs and Merita selling 127m ordinary shares in the Finnish national telecoms operator for Eu23.75 off a closing price in Helsinki of Eu24.75. The stock has been well bid in the local market in recent months, with the traded stock reaching a high of just under Eu28 at the beginning of this month.
  • The Finnish government's divestment of Sonera has been an outstanding success, with global co-ordinators Goldman Sachs and Merita selling 127m ordinary shares in the Finnish national telecoms operator for Eu23.75 off a closing price in Helsinki of Eu24.75. The stock has been well bid in the local market in recent months, with the traded stock reaching a high of just under Eu28 at the beginning of this month.
  • n Bank Nederlandse Gemeenten NV
  • n BGB Finance (Ireland) plc Guarantor: Bankgesellschaft Berlin
  • Brazil and the Philippines this week demonstrated how the exchange of Brady bonds for global securities can boost market sentiment toward emerging market issuers when both sovereigns executed hugely successful debt swaps.
  • n GE Capital Canada Funding Co Guarantor: General Electric Capital Corp
  • Credit Suisse First Boston is hoping finally to launch the debut euro bond for Czech power company Cez today (Friday). The lead manager completed European roadshows in support of the issue last Monday (October), but the transaction's progress has been dogged variously by thin European investor demand, the issuer's insistence on an unpopular seven year tenor, an anti-trust investigation and continued controversy surrounding the award of the bookrunner's mandate.
  • International and local investors are indicating strong support of the Italian government's Eu9bn to Eu12bn sale of shares in Enel, the national electricity giant. The transaction has two weeks to go before pricing over the weekend of October 30 and the book of demand is already well covered. One salesman in London said: "International investors are most interested in buying large, liquid blue chip stocks - something that they can easily value, with decent cash earnings and a stable regulatory environment."
  • A rare example of a dollar swap arbitrage window tempted the Kingdom of Denmark to bring a $400m three year issue this week. The 6.375% notes due 2002 were lead managed by TMI and Lehman, and the proceeds were swapped to floating euros, the borrower confirmed. A spokesman added that the deal was swap-driven. The hunger for new debt currently exhibited by investors allowed the borrower to price this offering at 52bp over the 5.625% September 2001 Treasury.